Durect

Durect fails alcohol-associated hepatitis trial, plans phase 3 anyway as investors scorch stock
Fierce Biotech
Wed, 11/8/23 - 11:33 am
Durect
alcohol-associated hepatitis
hepatitis
clinical trials
Durect's non-opioid painkiller brushes aside checkered past, gaining FDA approval in shoulder surgeries
Endpoints
Tue, 02/2/21 - 11:12 pm
Durect
FDA
non-opioid pain treatments
Posimir
FDA staff highlight neurological safety concerns with Durect's pain drug
Endpoints
Wed, 01/15/20 - 10:47 am
FDA
Durect
anesthesia
Posimir
Durect shares rocked by midstage psoriasis flop, shifts focus to liver disease
Fierce Biotech
Fri, 01/3/20 - 09:46 am
Durect
clinical trials
psoriasis
DUR-928
Busy Gilead crew throws struggling biotech a lifeline, with some cash upfront and hundreds of millions in biobucks for HIV deal
Endpoints
Mon, 07/22/19 - 10:08 am
Gilead Sciences
Durect
HIV
hepatitis B
extended release
Novartis, Durect renegotiate $293M painkiller deal after phase 3 failure
Fierce Biotech
Thu, 05/10/18 - 09:46 am
Novartis
Durect
Posimir
post-operative pain
clinical trials
Novartis pushes further into pain with Durect deal
BioPharma Dive
Tue, 05/9/17 - 10:45 pm
Novartis
Durect
Sandoz
biosimilars
generics
Posimir
R&D
Positive FDA Committee Vote on Vantrela Bodes Well for Remoxy
Investopedia
Fri, 06/10/16 - 04:04 pm
FDA
Vantrela
Teva Pharmaceutical
Pain Therapeutics
Durect
Remoxy
New name, but same old problems for Posimir as FDA hits Durect again
Fierce Biotech
Sat, 04/9/16 - 09:30 am
Posimir
FDA
Durect
Posidur
gall bladder surgery
4 More Key FDA Decisions in March
24/7 Wall St
Wed, 03/16/16 - 07:24 pm
FDA
Bioline Rx
Dynavax Technologies
Puma Biotechnology
Durect
FDA rejects Durect's pitch to market post-operative pain therapy
Fierce Biotech
Thu, 02/13/14 - 09:22 am
FDA
Durect
post-operative pain
Impax Labs will develop Durect's Eladur shingles pain patch in deal worth up to $63M
Yahoo/AP
Tue, 01/7/14 - 12:27 pm
Durect
shingles
pain patches
Eladur
Impax Labs
Durect says FDA is reviewing long-lasting surgery pain drug Posidur, with decision due in Feb.
Yahoo/AP
Thu, 06/20/13 - 11:03 am
Durect
FDA
Posidur
post-surgical pain
This Week in Biotech
Motley Fool
Sun, 05/12/13 - 11:02 am
GSK
Theravance
Breo Ellipta
Pain Therapeutics
Durect
Pfizer
Remoxy
Eli Lilly
enzastaurin
Durect: Pfizer Hints At Progress With Remoxy
Seeking Alpha
Fri, 05/3/13 - 12:55 pm
Durect
Remoxy
Pfizer